Denbury Resources Inc. (NYSE:DNR)
On Tuesday, Denbury Resources Inc. (NYSE:DNR)’s shares declined -3.73% to $3.61.
DNR has beta value of 2.50. The company has the market capitalization of $1.32 billion. Return on assets ratio of the company was -29.10% while its return on equity ratio was -70.40%. ATR value of company was 0.34 while stock volatility for week was 9.50% while for month was 9.13%. Debt to equity ratio of the company was -1.58 and its current ratio was 1.20.
The mean estimate for the short term price target for Denbury Resources Inc. (NYSE:DNR) stands at $4.55 according to 16 Analysts. The higher price target estimate for the stock has been calculated at $8.00 while the lower price target estimate is at $1.00.
Analysts mean recommendation for the stock is -3.10. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Denbury Resources Inc. is an independent oil and natural gas company. The Company’s operations are focused in two operating areas: the Gulf Coast and Rocky Mountain regions.
Target Corporation (NYSE:TGT)
Target Corporation (NYSE:TGT)’s shares gained 0.87% to $72.94.
TGT is currently valued at $45.06 billion. The company has 628.43 million shares outstanding and 86.90% shares of the company were owned by institutional investors. The company has 0.62 value in price to sale ratio while price to book ratio was recorded as 3.32. The company exchanged hands with 9.08 million shares as compared to its average daily volume of 5.52 million shares. It beta stands at 0.57.
The mean estimate for the short term price target for Target Corporation (NYSE:TGT) stands at $84.91 according to 22 Analysts. The higher price target estimate for the stock has been calculated at $108.00 while the lower price target estimate is at $72.00.
Analysts mean recommendation for the stock is 2.40. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Target Corporation is engaged in providing everyday essentials and fashionable, and differentiated merchandise at discounted prices. The Company offers its products through stores, online or through mobile devices.
EnteroMedics Inc (NASDAQ:ETRM)
At the end of Tuesday’s trade, EnteroMedics Inc (NASDAQ:ETRM)‘s shares surged 8.72% to $0.183.
ETRM offered 42.90% EPS for prior five years. The company has -432.90% return on equity value. The company has $18.17 billion market capitalizations and the institutional ownership was 26.60%. Its price to book ratio was 2.62. Volatility of the stock was 20.63% for the week while for the month booked as 18.38%.
The mean estimate for the short term price target for EnteroMedics Inc (NASDAQ:ETRM) stands at $2.45 according to 5 Analysts. The higher price target estimate for the stock has been calculated at $7.00 while the lower price target estimate is at $1.00.
Analysts mean recommendation for the stock is 1.80. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
EnteroMedics Inc. (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.